Status:
WITHDRAWN
Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Cervical Cancer
Condylomata Acuminata
Eligibility:
FEMALE
16-26 years
Phase:
PHASE2
Brief Summary
This study is to evaluate an investigational vaccine with the following objectives: (1) To demonstrate prevention of cervical, vulvar, and vaginal cancers and related precancers, external genital lesi...
Eligibility Criteria
Inclusion
- Female, between the ages of 16 and 26
Exclusion
- History of an abnormal PAP test or abnormal cervical biopsy result
- History of external genital/vaginal warts
- History of positive HPV test
- Currently a user of any illegal drugs or an alcohol abuser
- Are pregnant
- Currently enrolled in another clinical trial
- Currently has or has a history of certain medical conditions or is currently taking or has taken certain medications (details will be discussed at the time of consent).
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00365443
Start Date
October 1 2006
Last Update
June 19 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.